Sotagliflozin wiki：Sotagliflozin: Uses
Sotagliflozin: Uses
2016年10月20日—SotagliflozinisanorallyadministereddualSGLT1/2inhibitorusedalongsideinsulintoimproveglycemiccontrolinpatientswithtype1 ...。其他文章還包含有：「Sotagliflozin」、「Sotagliflozin」、「SGLT2inhibitor」、「sotagliflozin」、「SotagliflozininPatientswithDiabetesandChronicKidney...」、「sotagliflozin」、「EffectofSotagliflozinonCardiovascularandRenalEvents...」、「Category」、「Sotagli...
查看更多 離開網站
Sotagliflozin
https://en.wikipedia.org
Sotagliflozin, sold under the brand name Inpefa among others, is a medication used to reduce the risk of death due to heart failure.
Sotagliflozin
https://pubchem.ncbi.nlm.nih.g
It is an inhibitor of SGLT1 and SGLT2 that is approved to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure ...
SGLT2 inhibitor
https://en.wikipedia.org
Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the FDA in May 2023, to reduce the risk of cardiovascular death, hospitalization for ...
sotagliflozin
https://www.wikidata.org
Statements ; instance of · type of chemical entity ; subclass of · chemical compound ; chemical structure · Sotagliflozin structure.svg 885 × 385; 20 KB ; mass.
Sotagliflozin in Patients with Diabetes and Chronic Kidney ...
https://www.nejm.org
Sotagliflozin resulted in a lower risk of the composite of deaths from cardiovascular causes, hospitalizations for heart failure, and urgent visits for heart ...
sotagliflozin
https://en.wiktionary.org
sotagliflozin (uncountable). An inhibitor of glucose transporters used as a drug to counter diabetes · Categories: English lemmas · English nouns ...
Effect of Sotagliflozin on Cardiovascular and Renal Events ...
https://www.acc.org
The results of this trial indicate that sotagliflozin has salutary effects on CV outcomes among patients with T2DM and CKD.
Category
https://commons.wikimedia.org
Media in category Sotagliflozin. The following 3 files are in this category, out of 3 total. Sotagliflozin structure.svg 885 × 385; 20 KB.
Sotagliflozin Decreases Postprandial Glucose and Insulin ...
https://academic.oup.com
Sotagliflozin delayed and blunted intestinal glucose absorption after meals, resulting in lower PPG and insulin levels.